Displaying 41 - 60 of 695
FTC and DOJ Announce Additional Workshops on the 2023 Draft Merger Guidelines
Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc
Biopharmaceutical Giant Amgen to Settle FTC and State Challenges to its Horizon Therapeutics Acquisition
FTC and DOJ to Co-Host 2023 Draft Merger Guidelines Workshop on September 5
FTC Secures Settlement with ICE and Black Knight Resolving Antitrust Concerns in Mortgage Technology Deal
FTC and DOJ Seek Comment on Draft Merger Guidelines
Altria Group/JUUL Labs, In the Matter of
The Federal Trade Commission filed an administrative complaint alleging that Altria Group, Inc. and JUUL Labs, Inc. entered a series of agreements, including Altria’s acquisition of a 35% stake in JUUL, that eliminated competition in violation of federal antitrust laws. According to the complaint, this series of agreements involved Altria ceasing to compete in the U.S. market for closed-system electronic cigarettes in return for a substantial ownership interest in JUUL, by far the dominant player in that market. In an initial decision announced on Feb. 24, 2022, Chief Administrative Law Judge D. Michael Chappell dismissed the antitrust charges in the complaint.
16 CFR Parts 801 and 803: Premerger Notification; Reporting and Waiting Period Requirements
FTC and DOJ Propose Changes to HSR Form for More Effective, Efficient Merger Review
Statement of Chair Lina M. Khan Joined by Commissioners Slaughter and Bedoya Regarding Proposed Amendments to the Premerger Notification Form and the Hart-Scott-Rodino Rules
FTC Staff Opposes State Legislation in North Carolina Designed to Shield UNC Health System from Antitrust Enforcement
Amgen Inc. and Horizon Therapeutics plc, FTC v.
FTC Sues to Stop the Potentially Illegal Integration of New Orleans Area Hospitals Over Failure to Follow Federal Reporting Law
Intercontinental Exchange, Inc. and Black Knight, Inc., FTC v.
FTC Staff Seeks Court Order Preventing ICE from Consummating its Acquisition of Rival Black Knight Pending Agency Administrative Challenge
FTC Files Amicus Brief in Sage Chemical vs. Supernus Pharmaceutical Supporting Competition in the Market for Drug Used to Treat Advanced Parkinson’s Disease
Sage Chemical, Inc. et al. v. Supernus Pharmaceuticals, Inc. et al.
FTC Acts to Block Deal Combining the Two Top Mortgage Loan Technology Providers
Displaying 41 - 60 of 695